This will happen in a $1.4 bn deal. In May, Shanghai Fosun had made a non-binding proposal to buy Gland Pharma, which is backed by KKR & Co, to boost its drug manufacturing and research and development capacity.

Shanghai Fosun Pharmaceutical to sign an agreement to buy controlling stake in Gland Pharma

Leave a Reply

Your email address will not be published. Required fields are marked *